"NIH 3T3 Cells" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A continuous cell line of high contact-inhibition established from NIH Swiss mouse embryo cultures. The cells are useful for DNA transfection and transformation studies. (From ATCC [Internet]. Virginia: American Type Culture Collection; c2002 [cited 2002 Sept 26]. Available from http://www.atcc.org/)
| Descriptor ID |
D041681
|
| MeSH Number(s) |
A11.251.210.100.550 A11.329.228.100.550
|
| Concept/Terms |
NIH 3T3 Cells- NIH 3T3 Cells
- 3T3 Cell, NIH
- Cell, NIH 3T3
- Cells, NIH 3T3
- NIH 3T3 Cell
- NIH-3T3 Cells
- Cell, NIH-3T3
- Cells, NIH-3T3
- NIH-3T3 Cell
- 3T3 Cells, NIH
|
Below are MeSH descriptors whose meaning is more general than "NIH 3T3 Cells".
Below are MeSH descriptors whose meaning is more specific than "NIH 3T3 Cells".
This graph shows the total number of publications written about "NIH 3T3 Cells" by people in this website by year, and whether "NIH 3T3 Cells" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
| 2004 | 0 | 2 | 2 |
| 2005 | 0 | 3 | 3 |
| 2006 | 0 | 6 | 6 |
| 2007 | 0 | 3 | 3 |
| 2008 | 0 | 1 | 1 |
| 2009 | 0 | 2 | 2 |
| 2010 | 0 | 3 | 3 |
| 2011 | 0 | 4 | 4 |
| 2012 | 0 | 4 | 4 |
| 2013 | 0 | 7 | 7 |
| 2014 | 0 | 2 | 2 |
| 2015 | 0 | 3 | 3 |
| 2016 | 0 | 4 | 4 |
| 2017 | 0 | 1 | 1 |
| 2018 | 0 | 2 | 2 |
| 2019 | 0 | 1 | 1 |
| 2021 | 0 | 1 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "NIH 3T3 Cells" by people in Profiles.
-
Abu Rabe D, Chdid L, Lamson DR, Laudeman CP, Tarpley M, Elsayed N, Smith GR, Zheng W, Dixon MS, Williams KP. Identification of Novel GANT61 Analogs with Activity in Hedgehog Functional Assays and GLI1-Dependent Cancer Cells. Molecules. 2024 Jun 28; 29(13).
-
Gunther G, Malacrida L, Jameson DM, Gratton E, S?nchez SA. LAURDAN since Weber: The Quest for Visualizing Membrane Heterogeneity. Acc Chem Res. 2021 02 16; 54(4):976-987.
-
Marikawa Y, Alarcon VB. RHOA activity in expanding blastocysts is essential to regulate HIPPO-YAP signaling and to maintain the trophectoderm-specific gene expression program in a ROCK/actin filament-independent manner. Mol Hum Reprod. 2019 02 01; 25(2):43-60.
-
Sierra-Fonseca JA, Bracamontes C, Saldecke J, Das S, Roychowdhury S. Activation of ?- and a2-adrenergic receptors stimulate tubulin polymerization and promote the association of G?? with microtubules in cultured NIH3T3 cells. Biochem Biophys Res Commun. 2018 09 03; 503(1):102-108.
-
Wei H, Landgraf D, Wang G, McCarthy MJ. Inositol polyphosphates contribute to cellular circadian rhythms: Implications for understanding lithium's molecular mechanism. Cell Signal. 2018 04; 44:82-91.
-
Malacrida L, Jameson DM, Gratton E. A multidimensional phasor approach reveals LAURDAN photophysics in NIH-3T3 cell membranes. Sci Rep. 2017 08 23; 7(1):9215.
-
Youn UJ, Sripisut T, Miklossy G, Turkson J, Laphookhieo S, Chang LC. Bioactive polyprenylated benzophenone derivatives from the fruits extracts of Garcinia xanthochymus. Bioorg Med Chem Lett. 2017 08 15; 27(16):3760-3765.
-
Jiang N, Wu J, Leng T, Yang T, Zhou Y, Jiang Q, Wang B, Hu Y, Ji YH, Simon RP, Chu XP, Xiong ZG, Zha XM. Region specific contribution of ASIC2 to acidosis-and ischemia-induced neuronal injury. J Cereb Blood Flow Metab. 2017 Feb; 37(2):528-540.
-
Morales-Cruz M, Cruz-Monta?ez A, Figueroa CM, Gonz?lez-Robles T, Davila J, Inyushin M, Loza-Rosas SA, Molina AM, Mu?oz-Perez L, Kucheryavykh LY, Tinoco AD, Griebenow K. Combining Stimulus-Triggered Release and Active Targeting Strategies Improves Cytotoxicity of Cytochrome c Nanoparticles in Tumor Cells. Mol Pharm. 2016 08 01; 13(8):2844-54.
-
Chung SS, Oliva B, Dwabe S, Vadgama JV. Combination treatment with flavonoid morin and telomerase inhibitor MST-312 reduces cancer stem cell traits by targeting STAT3 and telomerase. Int J Oncol. 2016 Aug; 49(2):487-98.